Aggressive colon cancer treatment poses significant challenges. This study investigates the
potential of innovative carbohydrate-based nanoparticles for targeted Capecitabine (CTB) …

Colorectal cancer is cancer that starts in colon and rectum. As the colon and rectum are the
most interior part of gastrointestinal tract, it is a great challenge to target drug to colon and …

Background Colorectal cancer causes numerous deaths despite many treatment options.
Capecitabine (CAP) is the standard chemotherapy regimen for colorectal cancer, and …

The goal of this research was to find a way to enhance the pharmacological activity of
Capecitabine (CAP) and Thymoquinone (TQ) while also decreasing the likelihood of drug …

Colon cancer is one of the most life-threatening cancers with high incidence and mortality
rates. Current first-line treatments are ineffective and possess many unwanted effects. The …

The objective of this investigation was to fabricate nanoparticles consisting of Imatinib
mesylate-poly sarcosine-loaded chitosan/carrageenan in order to attain prolonged drug …

N-trimethyl chitosan (TMC) is a multifunctional polymer that can be used in various
nanoparticle forms in the pharmaceutical, nutraceutical and biomedical fields. In this study …

Colorectal cancer (CRC) is considered a lethal cancer all around the world, and its
incidence has been reported to be increasing. Chemotherapeutic drugs commonly used for …

A gastric cancer angiogenesis marker peptide, GX1, is promising to be a desirable ligand for
anti-angiogenesis targeted drug of gastric cancer treatment. In this study, GX1 was utilized to …

Cancer was ranked as the second leading cause of death, and colon cancer is recognized
as third most common cancer worldwide with high morbidity and mortality …